GlassScriptPhysician profile
Kyle T Jones
NPI 1164603262
$2,379.47
in general payments reported to CMS, 2019-2025
21 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $661 · 2022: $788 · 2023: $318 · 2024: $309 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $451.22 | 2021-2025 | Farxiga, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $234.37 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $215.49 | 2021-2024 | Trintellix |
| Lilly USA, LLC | $164.70 | 2021-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $163.24 | 2021-2025 | Ozempic |
| Amgen INC. | $154.29 | 2021-2025 | Repatha, Otezla, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.05 | 2021-2022 | |
| Glaxosmithkline, LLC. | $135.84 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Otsuka America Pharmaceutical, INC. | $126.68 | 2022-2025 | Rexulti |
| Abbott Laboratories | $100.34 | 2021-2022 | |
| Boston Scientific Corporation | $78.51 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Novartis Pharmaceuticals Corporation | $76.07 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $71.19 | 2021-2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $62.04 | 2021-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $41.06 | 2021-2023 | Verquvo, Belsomra |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $35.12 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $34.95 | 2021 | |
| Corium, LLC | $31.58 | 2023 | Azstarys |
| Teva Pharmaceuticals USA, INC. | $18.88 | 2023 | Austedo Xr |
| Viatris Specialty LLC | $17.17 | 2025 | Yupelri |
| Abiomed | $13.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.